Last reviewed · How we verify
Twinrix
At a glance
| Generic name | Twinrix |
|---|---|
| Sponsor | Aalborg University Hospital |
| Modality | Biologic |
| Therapeutic area | Other |
| Phase | FDA-approved |
Approved indications
Common side effects
Key clinical trials
- Immunogenicity of 2 Versus 3 Doses of Combined Hepatitis B Vaccines in 2-18 Months Old Children (PHASE4)
- Hepatitis B in Cystic Fibrosis and Latent Tuberculosis Respectively (NA)
- A Prospective Study of HBV Immunity and HBV Vaccination in Patients With NAFLD in Canada
- Determining Responses to Two Different Vaccines in HIV and HCV Infected Individuals (PHASE1)
- Indirect Effects of Pneumococcal Vaccine on Nasopharyngeal Carriage
- Combination Hepatitis A and B Vaccine to Induce Immunity in Non-responders (PHASE4)
- Immunogenicity of Gardasil and Twinrix and the Effect of a Dose of Gardasil or Cervarix Given 42 Months Later. (PHASE3)
- Effect of Risk Factors Likely to Influence Immuno of Combined Hepatitis A & B Vacc vs Monovalent Hepatitis A & B Vacc (PHASE4)
Primary sources
Every claim on this page is sourced from regulatory or scientific primary sources. See our editorial policy for full methodology.
| Source | Used for |
|---|---|
| ClinicalTrials.gov | Trial enrolment, design, endpoints, results |